共 220 条
- [11] Dunn J(2011)Improving the quality of drug research or simply increasing its cost? an evidence-based study of the cost for data monitoring in clinical trials Br J Clin Pharmacol 71 467-780
- [12] Cox T(2016)The impact of clinical trial monitoring approaches on data integrity and cost-a review of current literature Eur J Clin Pharmacol 72 399-84
- [13] Ghaneh P(2012)A systematic search for reports of site monitoring technique comparisons in clinical trials Clin Trials 9 777-444
- [14] Cunningham D(2008)Sensible approaches for reducing clinical trial costs Clin Trials. 5 75-660
- [15] Neoptolemos JP(2016)Enhancing clinical evidence by proactively building quality into clinical trials Clin Trials 13 439-1065
- [16] Tudur Smith C(2012)Clinical trials: rethinking How We ensure quality Drug Inf J 46 657-1276
- [17] Williamson P(2013)Randomized clinical trials–removing unnecessary obstacles N Engl J Med 369 1061-27
- [18] Jones A(2016)Risk indicator taxonomy for supervision of clinical trials on medicinal products Curr Med Res Opin 32 1269-124
- [19] Smyth A(2016)Risk based monitoring (RBM) tools for clinical trials: a systematic review Contemp Clin Trials 51 15-349
- [20] Hewer SL(2013)A systematic review of on-site monitoring methods for health-care randomised controlled trials Clin Trials 10 104-668